Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00861458 | Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State | PHASE1 | COMPLETED | 14 | — | — | Apr 1, 2009 | Jun 1, 2009 | Jul 8, 2009 | 1 | Belgium |
| Arm | Type | Description |
|---|---|---|
| PF-00868554 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Pharmacokinetics | DRUG | Single dose of 750 mg PF-00868554 as a solution and tablets. |
Inclusion Criteria: * Healthy volunteers. Exclusion Criteria: * Standard for healthy volunteers.